REGENXBIO
Mina Miljevic began their work experience in 2016 as an Associate at Dechert LLP. Mina worked there until 2020 when they joined Arnold & Porter Kaye Scholer LLP as an Associate. In 2022, they became a Senior Associate at Freshfields Bruckhaus Deringer, and in 2023, they started working as the Director, Corporate Counsel at REGENXBIO Inc.
Mina Miljevic completed their Bachelor of Arts at the University of Pennsylvania in 2013. Mina then pursued a Doctor of Law degree at Georgetown University Law Center, which they completed in 2016.
This person is not in any offices
REGENXBIO
4 followers
REGENXBIO is seeking to improve lives through the curative potential of gene therapy. Our NAV® Technology Platform has ushered in a new era of gene therapy innovation.